SPRINGFIELD, Ill. — The price of a 30-day supply of covered insulin for all people on state-regulated plans will be capped at $35 thanks to legislation passed by state Rep. Jenn Ladisch Douglass, D-Elmhurst.
“As one of the millions of Illinois residents living with diabetes, I know that insulin only works when it’s affordable and accessible to those who need it. Too many people have tragically lost their lives because they didn’t have access to this life saving medication, and that’s absolutely unacceptable,” Ladisch Douglass said. “These deaths are preventable, and that’s what this bill addresses.”
House Bill 2189 lowers the current co-pay cap on the total amount that a person is required to pay for a 30-day supply of covered prescription insulin drugs, for all people on state-regulated plans, from $100 to $35. The bill also creates a discount program so eligible individuals can purchase insulin at a discounted post-rebate price and pursue a reimbursement from their health insurer.
Before taking office, Ladisch Douglass volunteered as a citizen-advocate in support of insulin price caps and other health care affordability measures.
“This essential legislation proves that in Illinois, we value people’s lives over profit for this essential medication. Insulin only works when it’s affordable and accessible, and this bill will help people across Illinois access the medicine they need,” Ladisch Douglass said. “I applaud my colleagues on both sides of the aisle for getting this bill across the finish line, and I strongly urge the Governor to sign this legislation to help create a healthier Illinois.”
House Bill 2189 passed the Illinois General Assembly with bipartisan support and will be considered by the Governor. For more information on Ladisch Douglass’ legislative agenda, please visit www.ilga.gov.